Izlaganje sa skupa
AN AUDIT TO COMPARE THE EFFICACY OF TREATMENT (AS INDICATED BY DISCHARGE RATES AND REDUCTION IN SUICIDALITY) AMONG PATIENTS WITH REFRACTORY DEPRESSION IN A BEDFORDSHIRE COMMUNITY MENTAL HEALTH TEAM RECEIVING AUGMENTATION THERAPY WITH EITHER MIRTAZEPINE OR ATYPICAL ANTIPSYCHOTICS
Sophie Butler
; Foundation Programme East Anglian Deanery, UK
Clare Holt
; Foundation Programme East Anglian Deanery, UK
Mark Agius
; South Essex Partnership University Foundation NHS Trust, UK; Department of Psychiatry, University of Cambridge, UK
Rashid Zaman
; South Essex Partnership University Foundation NHS Trust, UK; Department of Psychiatry, University of Cambridge, UK
Sažetak
In recent years, there has been particular interest in the use of augmentation. Potential augmentation regimes include the
addition of atypical antipsychotics (e.g. risperidone/olanzapine) or other antidepressants (e.g. mirtazepine). The purpose of this
audit was to compare patient outcomes between groups receiving different augmentation strategies. Overall we found that
augmentation with mirtazepine resulted in better outcomes in terms of both discharge rates and in terms of reduction in suicidality
than augmentation with atypical antipsychotics
Ključne riječi
augmentation; mirtazepine; atypical antipsychotics; suicidality; discharge rates
Hrčak ID:
264852
URI
Datum izdavanja:
1.9.2011.
Posjeta: 180 *